An estimated 15 million Americans are currently taking semaglutide weight loss drugs, which are proven to impact alcohol ...

Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as  GLP-1s.

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Successful initial administration and full enrollment in first-in-human LIBERATE-1 ™ study of NPM-115 (exenatide implant) in obese and ...

As the popularity of weight loss drugs like Ozempic continues to climb, a disturbing pattern is emerging — and it's impacting ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may ...

Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen ...

A new study suggests that restoring the pleasure of eating – not suppressing it – may help people eat more intentionally and ...